Abstract: The present invention is directed to a dental mount for receiving and retaining a plurality of different dental ceramic blocks used in dental restoration treatments, wherein the dental mount comprises a substantially flat front face having a plurality of dental ceramic block receiving holes located thereon; each of the dental ceramic block receiving holes being dimensioned to form a retaining fit with any one of the different dental ceramic blocks. The advantage of providing a dental mount with dedicated holes for retaining any one of the dental ceramic blocks is that the dental mount can be used to comparatively present all the different types of dental ceramic blocks next to one another in an organised and graded manner so that a dentist may make quick and accurate comparisons between the different types of dental ceramic blocks. Furthermore, the dentist can quickly assess their stock levels by glancing at the dental mount.

Abstract: Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (CAT). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods.

Abstract: A method of assigning the UNIX computers in a network to one of a plurality of groups called zones, of creating independent sets of UNIX identity information for each network entity (user or group) for separate zones, and of associating an entity's sets of UNIX entity information with a single global entity record for the entity in the network's identity resolver. A further method of allowing a UNIX computer to request entity information from the identity resolver, and of the identity resolver returning resolved entity information appropriate for the requesting computer's zone. A further method of managing sets of zone-specific UNIX identity information in the identity resolver to ensure that entity names and entity identification numbers are not duplicated within a zone and to all the same names and numbers to be duplicated across zones. Other embodiments are also described.

Abstract: A transmitter has a power amplifier (40) to amplify an input signal having amplitude modulation, a supply voltage controller (10) to control a supply voltage of the power amplifier (40) according to the envelope, a sensor (R1) for sensing a modulation of a current drawn by the power amplifier (40), a delay detector (20) for detecting a delay of the controlled supply voltage relative to the sensed current, and a delay adjuster (30) for compensating the relative delay according to the detected delay. By sensing a current drawn, the delay detected can include any delay contributed by the power amplifier (40) up to that point, and yet avoid the more complex circuitry needed to derive the delay from an output of the power amplifier. Thus the distortion and out of band emissions caused by differential delays can be reduced more effectively.

Abstract: The present invention relates to human secreted polypeptides, and isolated nucleic acid molecules encoding said polypeptides, useful for diagnosing and treating immune disorders and diseases. Antibodies that bind these polypeptides are also encompassed by the present invention. Also encompassed by the invention are vectors, host cells, and recombinant and synthetic methods for producing said polynucleotides, polypeptides, and/or antibodies. The invention further encompasses screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further encompasses methods and compositions for inhibiting or enhancing the production and function of the polypeptides of the present invention.

Abstract: The present invention provides a laterally diffused metal oxide semiconductor (LDMOS) transistor and a method for fabricating it. The LDMOS transistor includes an n-type epitaxial layer formed on a p-type substrate, and an asymmetric conductive spacer which acts as its gate. The LDMOS transistor also includes a source and a drain region on either side of the asymmetric conductive spacer, and a channel region formed by ion-implantation on the asymmetric conductive spacer. The height of the asymmetric conductive spacer increases from the source region to the drain region. The channel region is essentially completely under the asymmetric conductive spacer and has smaller length than that of the channel region of the prior art LDMOS transistors. The LDMOS transistor of the present invention also includes a field oxide layer surrounding the active region of the transistor, and a thin dielectric layer isolating the asymmetric conductive spacer from the n-type epitaxial layer.

Abstract: The present invention relates to human secreted polypeptides, and isolated nucleic acid molecules encoding said polypeptides, useful for diagnosing and treating immune disorders and diseases. Antibodies that bind these polypeptides are also encompassed by the present invention. Also encompassed by the invention are vectors, host cells, and recombinant and synthetic methods for producing said polynucleotides, polypeptides, and/or antibodies. The invention further encompasses screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further encompasses methods and compositions for inhibiting or enhancing the production and function of the polypeptides of the present invention.

Abstract: The present invention concerns the ?-glutamylcysteine treatment to reduce oxidative damage caused by ischemia/reperfusion events such as pulmonary hypertension, transplant, cardiac bypass and other surgeries, and trauma. In specific embodiments, preservation methods and apparatuses for preserving tissue for transplantation purposes is provided.

Abstract: A method and apparatus for non-contact measurement of a media stack in an image production device is disclosed that may include detecting the position of an unfluffed media stack, setting a desired media stack height by changing a media elevator position using a media elevator control unit based on the detected unfluffed media stack position, determining if printing and fluffing has started, wherein if it is determined that printing and fluffing has started, detecting the position of the transition between the fluffed and unfluffed portions of the media stack using the one or more sensors, determining if the position of the transition between the fluffed and unfluffed portions of the media stack is below a predetermined threshold, wherein if it is determined that the position of the transition between the fluffed and unfluffed portions of the media stack is below the predetermined threshold, setting the desired media stack height by changing the media elevator position based on the detected position of the tr

Abstract: System and methods for directing sheet media to one of multiple output paths is described. A multi-path gating system includes a multi-positionable gate including a fixed pivotable input end for receiving sheet media and a movable output end for routing the sheet media to one of multiple output paths. The multi-path gating system also includes an actuator configured to control the position of the output end of the multi-positionable gate, wherein the actuator orients the output end of the gate forming an output path for the sheet media.

Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.

Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.

Abstract: Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (CAT). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods.

Abstract: A method and apparatus for non-contact measurement of a media stack in an image production device is disclosed that may include detecting the position of an unfluffed media stack, setting a desired media stack height by changing a media elevator position using a media elevator control unit based on the detected unfluffed media stack position, determining if printing and fluffing has started, wherein if it is determined that printing and fluffing has started, detecting the position of the transition between the fluffed and unfluffed portions of the media stack using the one or more sensors, determining if the position of the transition between the fluffed and unfluffed portions of the media stack is below a predetermined threshold, wherein if it is determined that the position of the transition between the fluffed and unfluffed portions of the media stack is below the predetermined threshold, setting the desired media stack height by changing the media elevator position based on the detected position of the tr

Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.

Abstract: The present invention relates to a novel human gene encoding a polypeptide which is a member of the Cytokine Receptor family. More specifically, the present invention relates to a polynucleotide encoding a novel human polypeptide named Cytokine Receptor Common Gamma Chain Like, or “CRCGCL.” This invention also relates to CRCGCL polypeptides, as well as vectors, host cells, antibodies directed to CRCGCL polypeptides, and the recombinant methods for producing the same. Also provided are diagnostic methods for detecting disorders related to the immune system, and therapeutic methods for treating diagnosing, detecting, and/or preventing such disorders. The invention further relates to screening methods for identifying agonists and antagonists of CRCGCL activity.

Abstract: A multi-mode radio transmitter for use in mobile radio cellular standards, such as 2G, 2.5G and 3G, and a method of operating the transmitter in which an input signal is modulated independently of controlling the drive of a power amplifier (PA) module (40). The transmitter comprises circuitry (12, 60) for extracting the phase (?) and amplitude (R) components from envelope information in the input signal. A modulator (110) uses the phase component (?) to produce a constant-envelope signal comprising a phase modulated real signal at the transmitter frequency. This signal is multiplied in a multiplier (72) with either a fixed bias voltage (Vg1) to produce a constant envelope signal or a low level envelope tracking signal derived from an amplitude component (R) by a first amplitude control circuit (78) to produce a signal modulated exactly by the amplitude component. An output from the multiplier is applied to the PA module (40) having a control input (41).

Abstract: A mechanism for the deployment of asynchronous agentless agent functionality in clustered environments. An agentless agent execution node in an agentless agent execution node cluster receives a context message comprising an asynchronous operation request and an execution context from a messaging service. The agent node determines if an entry for the execution context exists in an execution context state table of the agent node. If no entry exists, the agent node creates an execution context entry in the execution context state table of the agent node. The agent node retrieves an asynchronous code module associated with the asynchronous operation from a central repository. The asynchronous code module is then executed on a managed resource to detect asynchronous code events occurring on the managed resource. When asynchronous code events are detected at the managed resource, the agent node sends a message comprising the asynchronous code events to a management server.

Abstract: A mainshaft assembly for a gearbox and a gearbox embodying such a mainshaft assembly are disclosed. The mainshaft assembly comprises a mainshaft (44), and several drive gears (31 . . . 36), each carried for rotation about the mainshaft, each drive gear having a different number of teeth. The assembly includes first and a second hub (50, 50?), each being associated with a respective drive gear, each hub having a dog ring (54, 54?) operable to selectively couple with the drive gear causing it to rotate with the hub or uncouple from the drive gear to allow the drive gear to rotate with respect to the hub. A respective drive connection including a cage (42) and pawls (64, 66) is associated with each hub and selectively connects the hub to the mainshaft for rotation with it or to allow rotation with respect to it when the pawls are displaced against a spring bias.

Abstract: A constant velocity (CV) joint assembly comprising a CV joint and an input member is disclosed. The CV joint that has a cage and a gear between which rotational drive can be transmitted. The input member is connected to the cage of the CV joint for transmission of rotational drive about an axis from an external component to the CV joint. The rotational drive is transmitted between the cage and the input member through interacting drive faces that are disposed in a plane that is generally parallel to the axis. The cage and the input member are retained in interconnection by fastening means that are not responsible for transmission of rotational drive between the cage and the input member. By separating the task of transmission of torque and retention of the connection between the cage and the input member, the fastening means required to perform the latter task can be comparatively light.